Distinctive symptoms
Register , to see more distinctive signs of diseases and studies 100% —
Register , to see more distinctive signs of diseases and studies 66% 100%
intrauterine infection
98%
—
nosocomial infections —
23%
arvi during pregnancy
90%
—
hepatitis chronic —
17%
mycoplasma
90%
—
chronic viral hepatitis —
17%
herpes
87%
2%
dark urine —
17%
cytomegalovirus
86%
3%
hepatitis A —
16%
diabetic cataract
76%
—
cholestasis —
15%
clamidiosis
73%
—
jaundice —
15%
general intoxication syndrome
81%
6%
light stool —
14%
thrombocytopenia in newborns
69%
—
acute hepatitis —
14%
pregnancy
73%
3%
heaviness in the hypochondrium —
14%
toxoplasmosis
67%
—
liver dysfunction —
14%
nephritic syndrome
67%
—
prolonged jaundice —
14%
viral pneumonia
65%
—
acute viral hepatitis —
14%
rubella
64%
—
hepatitis D —
14%
coxsackie
63%
—
bilirubin is elevated —
14%
intoxication
73%
10%
medicinal hepatitis —
14%
proteus syndrome
61%
—
hypertrophy biliary tract —
13%
cytomegalovirus hepatitis
60%
—
cirrhosis of the liver —
13%
bacteremia
67%
5%
dark feces —
12%
sepsis
66%
5%
hepatic encephalopathy —
12%
inflammation
66%
6%
liver pain —
12%
postpartum infections
57%
—
hepatic coma —
12%
Friedlander 's pneumonia
57%
—
consequences of infection —
11%
bach flower
57%
—
high temperature —
11%
enterovirus infection
55%
—
colorless urine —
11%
pregnancy complications
60%
3%
joint pain —
11%
bacterial pneumonia
61%
4%
encephalopathy —
11%
damage to the uterus
54%
—
vomiting —
10%
hemolytic disease of newborns
54%
—
recovery period —
10%
viral meningoencephalitis
54%
—
nausea —
10%
pseudomonas infection
53%
—
cytolysis syndrome —
10%
herpetic hepatitis
59%
4%
heaviness in the right hypochondrium —
10%
fetoplacental insufficiency
53%
—
skin problems —
10%
gonorrhea
53%
—
the skin is dark —
10%
scarlet
52%
—
stage of recovery —
10%
salpingitis
52%
—
feeling of heat —
10%
typhlitis
52%
—
fulminant hepatitis —
10%
intrauterine fetal development delay
52%
—
joint diseases —
10%
malaria
56%
3%
bleeding —
10%
endocervicitis
51%
—
drug disease —
10%
connective tissue dysplasia
51%
—
palpitations —
10%
enterocolitis
50%
—
yellowness of mucous membranes —
10%
hemolytic anemia
50%
—
moderate condition —
10%
pneumonia
54%
3%
antigens to hepatitis B increased —
10%
infectious colitis
49%
—
liver cancer —
10%
discirculatory encephalopathy
48%
—
hemorrhages on the skin —
10%
interstitial pneumonia
48%
—
bitterness in the mouth —
10%
liver problems
62%
13%
violation of the stool —
10%
duodenitis
46%
—
itchy skin —
10%
meningoencephalitis
46%
—
antigens to hepatitis B reduced —
10%
adrenal insufficiency
45%
—
increased alt —
10%
hydrocephalus
45%
—
hepatitis in the anamnesis —
10%
viral diarrhea
50%
3%
stool mushy —
10%
cardiomyopathy
44%
—
urticaria skin —
9%
vulvovaginitis
44%
—
quickly gets tired —
9%
vulva infections
44%
—
sclerosing cholangitis —
9%
cataract
44%
—
exanthema —
9%
colitis
43%
—
cholestatic hepatitis —
9%
intra-phase infections
43%
—
high fever —
9%
gastrointestinal problems
58%
13%
increased ast —
9%
blood diseases
56%
11%
urine light —
9%
encephalitis
43%
—
acute liver failure —
9%
up circulatory disorders
49%
4%
constant weakness —
9%
ARVI
42%
—
nosebleeds in the afternoon —
9%
streptococci
42%
—
feeling of bruising —
9%
hemorrhagic syndrome
51%
7%
brown urine —
9%
vascular sclerosis
42%
—
liver failure —
9%
toxicosis
42%
—
increase of the alkaline phosphatase —
9%
impaired uterine function
42%
—
density is increased —
9%
heart dysfunction
48%
5%
vaccination —
9%
appendages of the uterus
41%
—
nosebleed —
9%
atherosclerosis of blood vessels
41%
—
abdominal distension —
9%
leukoencephalitis
40%
—
attacks of pain —
9%
hepatosplenomegaly
46%
4%
tachycardia —
9%
fluid in the abdominal cavity
45%
3%
abdominal distension a —
9%
female pelvic organs
37%
—
increase ggtp —
9%
damage to the nervous system
48%
9%
consequences of taking medications —
9%
hormonal disorders
36%
—
medicinal hepatotoxicity —
8%
lags behind in the development
36%
—
mononucleosis —
8%
diseases of the gastrointestinal tract
47%
9%
papules —
8%
cerebral circulation disorder
39%
2%
amoebiasis —
8%
enlargement of the liver and spleen
44%
7%
positive —
8%
cerebrovascular disease unspecified
39%
2%
yellow fever —
8%
consequences of childbirth
38%
2%
cholangitis —
8%
organic brain damage
38%
2%
toxic liver —
8%
hypoxia
37%
2%
poor sleep —
8%
thrombocytopenia
40%
5%
listeriosis —
8%
inflammatory bowel diseases
39%
5%
coma —
8%
not enough time
38%
4%
bradycardia —
8%
diabetes mellitus
37%
3%
intrahepatic cholestasis —
8%
initial cataract
30%
—
urticaria —
8%
enlarged liver
40%
8%
Acholia —
8%
brain damage
35%
3%
pain in the right hypochondrium —
8%
enlargement of the spleen
43%
11%
infectious mononucleosis —
8%
increased
43%
11%
toxic hepatitis —
8%
angiopathy
34%
4%
constant bloating —
8%
impaired arterial function
33%
4%
calcium —
8%
childhood diseases
33%
4%
amoebic liver abscess —
8%
viral hepatitis b
43%
16%
zpr fatigue from the disease —
8%
there are no complaints
33%
6%
complete lack of appetite —
8%